Menu Back toSession-4-Study-Designs

Clinical Statistics for Nonstatisticians


Session 4: Study Designs

Session Chair(s)

Rafe  Donahue, PhD

Rafe Donahue, PhD

  • Senior Director, Biometrics
  • Sierra Oncology, United States
Review advantages and disadvantages common in study designs used in drug development.
  • Objectives of study designs
  • Techniques to reduce or avoid bias
  • Parallel design
  • Cross-over design
  • Factorial design
  • Titration design
  • Group sequential design

Contact us


Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda and Event Logistics

Send Email
+1.215.442.6108